Medivolve Inc.
Medivolve Inc. (MEDVF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
medvf · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medivolve Inc. (MEDVF) measures how much investors pay for each dollar of the company's trailing earnings. MEDVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.61.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2006 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medivolve Inc.You MEDVF | $0M | N/A | — | -$0.61 |
 Biome Grow Inc. BIOIF | $0M | N/A | — | -$0.10 |
 Cannabis Global, Inc. CBGL | $0M | N/A | — | -$0.00 |
 Psykey, Inc. CEOS | $0M | 0.32x | — | $0.01 |
 Immunotech Laboratories, Inc. IMMB | $0M | N/A | — | -$0.00 |
 Instadose Pharma Corp. INSD | $0M | N/A | — | -$0.01 |
 LadRx Corporation LADX | $0M | N/A | — | -$3210.89 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-0.61 | — | |
2022-12-31 FY2022 | — | $-0.68 | — | |
2021-12-31 FY2021 | — | $-0.24 | — | |
2020-12-31 FY2020 | — | $-5.66 | — | |
2019-12-31 FY2019 | — | $-1.19 | — | |
2018-12-31 FY2018 | — | $-0.31 | — | |
2017-12-31 FY2017 | 0.00x | $1.39 | — | |
2016-12-31 FY2016 | — | $-0.59 | — | |
2015-12-31 FY2015 | — | $-2.48 | — | |
2014-12-31 FY2014 | — | $-4.54 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medivolve Inc. (MEDVF) measures how much investors pay for each dollar of the company's trailing earnings. MEDVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.61.
Frequently asked questions
MEDVF pe ratio · 6 questionsMEDVF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.61. Data sourced from Financial Modeling Prep via MEDVF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medivolve Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09